The discovery and development of HMG-CoA reductase inhibitors.

Regulation of the mevalonate pathway

Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906

All ras proteins are polyisoprenylated but only some are palmitoylated

Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,775

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630

Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.

(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,426

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

Endo, A., KURODA, M., & Tsujita, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954

Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity

Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 800

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

Influence of nicotinic acid on serum cholesterol in man

Altschul, R., Hoffer, A., & Stephen, J. D. (1955) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(55)90070-9 · Cited by 726

Statins

Wilson, P. W. F. (2014) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat06829

Statins

Anker, S. D., & von Haehling, S. (2005) · CRC Press eBooks · doi:10.1201/9781420048957.ch24

FARMACOGENÉTICA CARDIOVASCULAR

Sandrim, V. C., Rezende, V. B., & Tanus-Santos, J. E. (2006) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v39i4p535-542

Repurposing of Metabolic Drugs and Mitochondrial Modulators as an Emerging Class of Cancer Therapeutics with a Special Focus on Breast CancerPreprint

Parmar, H. S., Tripathi, V., Jaiswal, P., Sahu, K., Majumder, S. K., Kashyap, D., Dixit, A. K., & Jha, H. C. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4118479

Complementary Medications (Statins, Nicergoline, Naftidrofuryl) in Dementia

Yaman, A., & Yaman, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_422

Mechanisms and Evidence on Pancreatic Cancer Prevention

Hasanov, M., Montiel, M. F., Bhutani, M. S., & McAllister, F. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_25

Évaluation de l’effet des extraits des feuilles de Thymus vulgaris L. sur le profil lipidique des souris sous un régime riche en cholestérol

Cheurfa, M., & Allem, R. (2023) · Phytothérapie · doi:10.3166/phyto-2022-0358

Advanced therapeutics for targeting atherosclerosis

Bhunia, S. S., & Debnath, U. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00005-x

Bibliography

Hara, T. (2003) · Edward Elgar Publishing eBooks · doi:10.4337/9781843765660.00016

Familial Hypercholesterolaemia: Detection, diagnostic issues and collaboration between lipid clinics and general practice

Hedegaard, B. S. (2023) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau539425604

Applications of Microbial Fermentation to Food Products, Chemicals and Pharmaceuticals

(2021) · Wiley eBooks · doi:10.1002/9781119042792.part2

Human cardiometabolic health

Schroor, M. M. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230929ms

Avaliação de potenciais biomarcadores envolvidos no mecanismo de infecção do vírus Oropouche por metabolômica

Mor, N. C. (2021) · doi:10.47749/t/unicamp.2021.1165435

Changes in Blood Lipids and Enzymatic Reactions in Response to Atorvastatin Administration Following a High-Fat Diet in a NAFLD Rat Model

Eslami, Z., Kandi, Y. M., Norouzi, A., Moghanlou, A. E., Arabi, M. S., Kazeminejad, V., Alarzi, S. S. H., Saidi, A., & Joshaghani, H. (2022) · شهباز. · doi:10.61186/mlj.16.3.7 · Cited by 1

Hemmstoffe für Oxidoreduktasen

Klebe, G. (2023) · Springer eBooks · doi:10.1007/978-3-662-67209-9_27

Utilising Genetic Interaction Networks to Elucidate the Anticancer and Diabetogenic Activities

Hernandez, C. D. R. (2024) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.25365985

Translational Medicine and Implementation Science

da Luz, P. L., & Pêgo‐Fernandes, P. M. (2023) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2022.1416011123 · Cited by 1

Antidiabetics and Antilipemics from Nature

Vijayan, N., & Mousumi, D. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-9183-9_20

Statins and its Effects on Lipids and Glycemic Status: A Quasi-Experimental Study

Khan, S. H., Shahid, R., Hafeez, A., Gillani, M., Qureshi, Z. A., & Hafeez, J. (2024) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v74i2.8091

Evidence-based study of Hridayarnava Rasa: An Ayurvedic formulation in experimentally induced atherosclerotic cardiovascular disease

Chitra, S., Jamadagni, S. B., Gaidhani, S. N., Ilavarasan, R., & Thri, V. E. N. (2024) · Journal of Drug Research in Ayurvedic Sciences · doi:10.4103/jdras.jdras_68_23

Therapeutic Potential of Alcoholic Extract from Lemna minor Linn. in Attenuating Atherosclerosis Induced by High-Fat Diet in Male Wistar Rats

Yamini, B. R., Sarkar, M., Joshi, K. P., Kumar, R. R., Kumar, M., Nishanth, D. R., & Chandini, C. H. (2024) · Toxicology International · doi:10.18311/ti/2024/v31i3/35843

Screening Methods and Models for Evaluation of Cardioprotective Plants and Phytochemicals

Mohammed, A. M. (2024) · Springer eBooks · doi:10.1007/978-981-97-4627-9_2

Changes in the drug discovery environment and the roles required of academic researchers

Nakayama, M. (2024) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.136.107

Oxidoreductase Inhibitors

Klebe, G. (2024) · Springer eBooks · doi:10.1007/978-3-662-68998-1_27

Statins: a tale of two pathways—cardiovascular savior, renal ineffectual

Yang, J. (2025) · Precision and Future Medicine · doi:10.23838/pfm.2025.00065

Adherence to lipid lowering therapy in primary prevention: talk with the patient, again and again

Langslet, G. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf260

Evaluation of Anti-atherosclerotic Activity of Arogyavardhani in High-fat Diet-Induced Atherosclerosis in Wistar Rats

Waghmare, C. S., & Nipate, S. S. (2025) · Journal of Ayurvedic and Herbal Medicine · doi:10.4103/jahm.jahm_6_25

Electrochemical Determination of Statin Drugs by Nanomaterial-based Electrodes

Coldibeli, B., Fix, G., & Sartori, E. R. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837675289-00306

Harnessing the power of traditional Chinese medicine for targeted protein degradation

Wu, Z., Zhu, B., Shou, Y., & Guo, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21816-3.00011-7

Avaliação da toxicidade reprodutiva da sinvastatina em Ratos machos adultos

Banzato, T. P. (2013) · Americanae (AECID Library)

Impact of serum squalene, postprandial lipoproteins, and cholesterol metabolism on coronary artery disease in postmenopausal women

Rajaratnam, R. (2000) · Työväentutkimus Vuosikirja

Mechanistic insights into the cholesterol-lowering activity of γ-oryzanol components

Cuccioloni, M., Juricic, H., Bonfili, L., Liu, Z., Abate, G., Uberti, D. L., Angeletti, M., Eleuteri, A. M., & Cecarini, V. (2026) · Food & Function · doi:10.1039/d5fo03394b

Photooxidation of mevastatin to access new hydroxylated statin derivatives

Lebeuf, R. (2026) · Tetrahedron Letters · doi:10.1016/j.tetlet.2026.156029

Fast–Slow Analysis of a Model for the Stimulation of Enzymatic Activity by a Competitive Inhibitor

Young, G., Riley, M. J., & Mitchell, C. C. (2026) · SIAM Journal on Life Sciences · doi:10.1137/25m1791639

Effets à long terme de l'atorvastatine à faible dose sur l'athérosclérose : une étude pluridisciplinaire chez un modèle animal, le lapin Watanabe

Tissier, F. (2015) · theses.fr (ABES) · doi:10.70675/4632f2c3zfaf6z4a5az99eaz48fe792697ae

Reconstruction mandibulaire segmentaire selon la technique des membranes induites avec greffe d’un biomatériau phosphocalcique, de moelle osseuse totale et de simvastatine

de Monès, E. (2015) · doi:10.70675/68c52dccz2086z4482z9eb6z3ccfca4f4144

Pharmacodynamic Interactions

Rathi, V. K., Dhingra, A. K., Saini, S., Singh, G., & Narwal, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814328126010006

Activation of secondary metabolism in Aspergillus and related filamentous fungi through regulatory engineering

Shyong, J., & Wang, C. C. C. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00043f

Dietary patterns, nutrition, and food–drug interactions during statin therapy: a narrative review

Mazur, M. J., Lenard, R., Önal, S., & Popiołek-Kalisz, J. (2026) · Global Perspectives on Nutrition · doi:10.1093/gpnutr/woag015

Clinically validated natural products: Mechanistic insights, therapeutic applications, and translational challenges

Asaduzzaman, M., Nahar, L., Biswas, M. S., & Rahman, M. M. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100887

Oxidative stress and atherosclerosis: from LDL oxidation and foam cell formation to plaque instability – three decades of evidence and remaining therapeutic challenges

Ji, L., & Du, H. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1968314

BindingDB Entry 50038042: Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents.

BindingDB (2012) · UC San Diego · doi:10.7270/q22r3sh6

BindingDB Entry 50018045: Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives.

BindingDB (2023) · UC San Diego · doi:10.7270/q2pv6qh4

BindingDB Entry 50037098: 2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery.

BindingDB (2012) · UC San Diego · doi:10.7270/q270825w

BindingDB Entry 50028155: Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression.

BindingDB (2010) · UC San Diego · doi:10.7270/q2r78f3m

BindingDB Entry 50030574: Synthesis and structure-activity relationships of N-(4-amino-2,6-diisopropylphenyl)-N'-(1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents.

BindingDB (2010) · UC San Diego · doi:10.7270/q24m94kr

BindingDB Entry 50031893: Peptide fragmentation as an approach in modeling of an active peptide and designing a competitive inhibitory peptide for HMG-CoA reductase.

BindingDB (2010) · UC San Diego · doi:10.7270/q2vm4cfg

Evidence-based data on Simvastatin: A 15-year experience

Susekov, A. V., Бадриевна, Г. Н., Zubareva, M., & Бойцов, С. А. (2010) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2010-16-3-238-249

Management of Cholesterol Disorders

Grundy, S. M. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_131

Ecosystem mycology: saprotrophs, and mutualisms between plants and fungi

Moore, D., Robson, G. D., & Trinci, A. P. J. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977022.014

Drug Therapy and Follow-Up

Eandi, M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7222-4_19

The isoprenoid biosynthesis pathway and regulation of osteoblast differentiation

Weivoda, M. M. (2011) · doi:10.17077/etd.fycowap2

Untitled work

(2000) · doi:10.1002/1097-0061(20000630)16:9

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 896

HMG-CoA reductase inhibitors as potent cholesterol lowering drugs

Tsujita, Y. (1994) · Gordon and Breach Science Publishers eBooks · Cited by 2

Lipid-lowering drugs: discovery and development of HMG-CoA reductase inhibitors.

Tsujita, Y. (1995) · 生体の科学

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760

The discovery of the HMG-CoA reductase inhibitors “statins”: A historical perspective

Endo, A. (2001) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.28.6_111